Patrick Horn, MD, discusses his recently published paper investigating the impact of left ventricular unloading on pulmonary congestion and pneumonia in patients with cardiogenic shock.
The final results of the physician-led NCSI Study demonstrate a 71% survival to discharge with greater than 90% native heart recovery when best practices are used.
Christophe Vandenbriele, MD, discusses data on combining Impella® with MitraClip to optimize outcomes in cardiogenic shock with acute severe mitral regurgitation secondary to AMI.
William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock.
Ameloot et al. report significant reduction in myocardial injury with target MAP between 80/85 and 100 mmHg in post-cardiac arrest patients with shock after AMI.
Yoshiki Sawa, MD, PhD, discusses a large multicenter study in Japan demonstrating high survival rates in AMI cardiogenic shock patients receiving the Impella heart pump.
To the surprise of all the treating cardiologists, the patient presented with an ejection fraction of 5%, which improved to 55% on Day 6 after support with Impella RP® and Impella CP®.
NPS-1674
This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].
The Protected PCI community
is now on HeartRecovery.com
Providing education and training to help health care professionals
recover hearts, oxygenate the body and save lives.
